Abstract
Lissencephaly is a devastating neurological disorder caused by defective neuronal migration. LIS1 (official symbol PAFAH1B1, for platelet-activating factor acetylhydrolase, isoform 1b, subunit 1) was identified as the gene mutated in individuals with lissencephaly, and it was found to regulate cytoplasmic dynein function and localization. Here we show that inhibition or knockdown of calpains protects LIS1 from proteolysis, resulting in the augmentation of LIS1 amounts in Lis1+/− mouse embryonic fibroblast cells and rescue of the aberrant distribution of cytoplasmic dynein, mitochondria and β-COP–positive vesicles. We also show that calpain inhibitors improve neuronal migration of Lis1+/− cerebellar granular neurons. Intraperitoneal injection of the calpain inhibitor ALLN to pregnant Lis1+/− dams rescued apoptotic neuronal cell death and neuronal migration defects in Lis1+/− offspring. Furthermore, in utero knockdown of calpain by short hairpin RNA rescued defective cortical layering in Lis1+/− mice. Thus, calpain inhibition is a potential therapeutic intervention for lissencephaly.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Alpha-synuclein facilitates to form short unconventional microtubules that have a unique function in the axonal transport
Scientific Reports Open Access 27 November 2017
-
Rab6a releases LIS1 from a dynein idling complex and activates dynein for retrograde movement
Nature Communications Open Access 19 June 2013
-
Post-natal treatment by a blood-brain-barrier permeable calpain inhibitor, SNJ1945 rescued defective function in lissencephaly
Scientific Reports Open Access 06 February 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout





References
Reiner, O. et al. Isolation of a Miller-Dieker lissencephaly gene containing G protein β-subunit–like repeats. Nature 364, 717–721 (1993).
Gleeson, J.G. et al. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 92, 63–72 (1998).
Pilz, D.T. et al. LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation. Hum. Mol. Genet. 7, 2029–2037 (1998).
Hirotsune, S. et al. Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat. Genet. 19, 333–339 (1998).
Hattori, M., Adachi, H., Tsujimoto, M., Arai, H. & Inoue, K. Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase. Nature 370, 216–218 (1994).
Vallee, R.B., Tai, C. & Faulkner, N.E. LIS1: cellular function of a disease-causing gene. Trends Cell Biol. 11, 155–160 (2001).
Wynshaw-Boris, A. Lissencephaly and LIS1: insights into the molecular mechanisms of neuronal migration and development. Clin. Genet. 72, 296–304 (2007).
Yamada, M. et al. LIS1 and NDEL1 coordinate the plus-end–directed transport of cytoplasmic dynein. EMBO J. 27, 2471–2483 (2008).
Sasaki, S. et al. Complete loss of Ndel1 results in neuronal migration defects and early embryonic lethality. Mol. Cell. Biol. 25, 7812–7827 (2005).
Hatten, M.E. Neuronal regulation of astroglial morphology and proliferation in vitro. J. Cell Biol. 100, 384–396 (1985).
Tanaka, T. et al. Lis1 and doublecortin function with dynein to mediate coupling of the nucleus to the centrosome in neuronal migration. J. Cell Biol. 165, 709–721 (2004).
Toyo-Oka, K. et al. Recruitment of katanin p60 by phosphorylated NDEL1, an LIS1 interacting protein, is essential for mitotic cell division and neuronal migration. Hum. Mol. Genet. 14, 3113–3128 (2005).
Schaller, M.D. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim. Biophys. Acta 1540, 1–21 (2001).
Parsons, J.T., Martin, K.H., Slack, J.K., Taylor, J.M. & Weed, S.A. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 19, 5606–5613 (2000).
Bhatt, A., Kaverina, I., Otey, C. & Huttenlocher, A. Regulation of focal complex composition and disassembly by the calcium-dependent protease calpain. J. Cell Sci. 115, 3415–3425 (2002).
Cuevas, B.D. et al. MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts. EMBO J. 22, 3346–3355 (2003).
Serrano, K. & Devine, D.V. Vinculin is proteolyzed by calpain during platelet aggregation: 95 kDa cleavage fragment associates with the platelet cytoskeleton. Cell Motil. Cytoskeleton 58, 242–252 (2004).
Franco, S.J. et al. Calpain-mediated proteolysis of talin regulates adhesion dynamics. Nat. Cell Biol. 6, 977–983 (2004).
Xi, X. et al. Tyrosine phosphorylation of the integrin β3 subunit regulates β3 cleavage by calpain. J. Biol. Chem. 281, 29426–29430 (2006).
Xie, Z., Sanada, K., Samuels, B.A., Shih, H. & Tsai, L.H. Serine 732 phosphorylation of FAK by Cdk5 is important for microtubule organization, nuclear movement and neuronal migration. Cell 114, 469–482 (2003).
Tsai, L.H., Delalle, I., Caviness, V.S. Jr. Chae, T. & Harlow, E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371, 419–423 (1994).
Tsai, L.H., Takahashi, T., Caviness, V.S. Jr. & Harlow, E. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 119, 1029–1040 (1993).
Goll, D.E., Thompson, V.F., Li, H., Wei, W. & Cong, J. The calpain system. Physiol. Rev. 83, 731–801 (2003).
Suzuki, K., Hata, S., Kawabata, Y. & Sorimachi, H. Structure, activation and biology of calpain. Diabetes 53 Suppl 1, S12–S18 (2004).
Arthur, J.S., Elce, J.S., Hegadorn, C., Williams, K. & Greer, P.A. Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol. Cell. Biol. 20, 4474–4481 (2000).
Yingling, J. et al. Neuroepithelial stem cell proliferation requires LIS1 for precise spindle orientation and symmetric division. Cell 132, 474–486 (2008).
McEvilly, R.J., de Diaz, M.O., Schonemann, M.D., Hooshmand, F. & Rosenfeld, M.G. Transcriptional regulation of cortical neuron migration by POU domain factors. Science 295, 1528–1532 (2002).
Gressens, P. Pathogenesis of migration disorders. Curr. Opin. Neurol. 19, 135–140 (2006).
Paylor, R. et al. Impaired learning and motor behavior in heterozygous Pafah1b1 (Lis1) mutant mice. Learn. Mem. 6, 521–537 (1999).
Amende, I. et al. Gait dynamics in mouse models of Parkinson's disease and Huntington's disease. J. Neuroeng. Rehabil. 2, 20 (2005).
Powell, E., Anch, A.M., Dyche, J., Bloom, C. & Richtert, R.R. The splay angle: A new measure for assessing neuromuscular dysfunction in rats. Physiol. Behav. 67, 819–821 (1999).
Bi, W. et al. Increased LIS1 expression affects human and mouse brain development. Nat. Genet. 41, 168–177 (2009).
Lee, M.S. et al. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360–364 (2000).
Patzke, H. & Tsai, L.H. Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29. J. Biol. Chem. 277, 8054–8060 (2002).
Chae, T. et al. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18, 29–42 (1997).
Kasai, Y., Inomata, M., Hayashi, M., Imahori, K. & Kawashima, S. Isolation and characterization of monoclonal antibodies against calcium-activated neutral protease with low calcium sensitivity. J. Biochem. 100, 183–190 (1986).
Lindsay, R.M. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J. Neurosci. 8, 2394–2405 (1988).
Tabata, H. & Nakajima, K. Efficient in utero gene transfer system to the developing mouse brain using electroporation: visualization of neuronal migration in the developing cortex. Neuroscience 103, 865–872 (2001).
Saito, T. & Nakatsuji, N. Efficient gene transfer into the embryonic mouse brain using in vivo electroporation. Dev. Biol. 240, 237–246 (2001).
Yamasaki, N. α-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol. Brain 1, 6 (2008).
Hampton, T.G., Stasko, M.R., Kale, A., Amende, I. & Costa, A.C. Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome. Physiol. Behav. 82, 381–389 (2004).
Acknowledgements
We thank S. Kawashima (Tokyo Metropolitan Institute of Medical Science) for providing us with a calpain-specific antibody (1D10A7)36. We thank Y. Funae, H. Iwao, T. Yamauch, M. Muramatsu and Y. Nagai for generous support and encouragement. We also thank Y. Kira, Y. Yabunaka and R. Zako for technical support, H. Nishimura and K. Fujimoto for mouse breeding, T. Bando for in utero injection and K. Nakanishi for behavior study. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan from the Ministry of Education, Science, Sports and Culture of Japan to M.S. and S.H. This work was also supported by The Sagawa Foundation for Promotion of Cancer Research, The Cell Science Research Foundation, The Japan Spina Bifida & Hydrocephalus Research Foundation, Takeda Science Foundation, The Hoh-ansha Foundation and Knowledge Cluster Initiative (Stage-2) Research Foundation to Shinji Hirotsune and by US National Institutes of Health grants NS41030 and HD47380 to A.W.-B. This work was also supported by a Grant-in-Aid for Scientific Research on Priority Areas -Integrative Brain Research (Shien)- from MEXT and a Grant-in-Aid from Neuroinformatics Japan Center to T.M.
Author information
Authors and Affiliations
Contributions
M.Y. conducted most of the experiments and wrote the manuscript. Y.Y. conducted most of the experiments. D.M. contributed in vivo analysis of mutant mice. T.T., M.K. and H.U. contributed to reaggregation assay of granular neurons. K.T. and T.M. contributed to behavior analysis. M.S. contributed to in utero injection. H.S. contributed to experiments regarding calpain inhibition. A.W.-B. wrote the manuscript and provided valuable suggestions. S.H. conducted the most of experiments and wrote the manuscript.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–7 and Supplementary Table 1 (PDF 2776 kb)
Rights and permissions
About this article
Cite this article
Yamada, M., Yoshida, Y., Mori, D. et al. Inhibition of calpain increases LIS1 expression and partially rescues in vivo phenotypes in a mouse model of lissencephaly. Nat Med 15, 1202–1207 (2009). https://doi.org/10.1038/nm.2023
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2023
This article is cited by
-
Alpha-synuclein facilitates to form short unconventional microtubules that have a unique function in the axonal transport
Scientific Reports (2017)
-
Calpain research for drug discovery: challenges and potential
Nature Reviews Drug Discovery (2016)
-
Post-natal treatment by a blood-brain-barrier permeable calpain inhibitor, SNJ1945 rescued defective function in lissencephaly
Scientific Reports (2013)
-
Rab6a releases LIS1 from a dynein idling complex and activates dynein for retrograde movement
Nature Communications (2013)
-
The exon junction complex component Magoh controls brain size by regulating neural stem cell division
Nature Neuroscience (2010)